Chimerix (CMRX) announced upcoming presentations at the 2024 Society for Neuro-Oncology, SNO, Annual Meeting, which will be held in Houston, TX ...

Wen, MD, Director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute. Details for the RANO 2.0 presentation as well as other pipeline presentations at SNO are as follows: Title: Response ...

Nanoscope Therapeutics, Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degeneration (AMD), today announced ...

The 7th edition of the Apollo Cancer Conclave, organized by Apollo Cancer Centers ,Mumbai was attended by over 2,000 Oncologist with over 400 faculty from leading national and international cancer ...

Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting initial data from Cohort 2 as monoth ...

Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting initial data from Cohort 2 as monotherapy in a ...

Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and ...

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine ...